GT Biopharma, Inc. (GTBP) Stock price, Description, News & Info

#Thinksabio latest news

$GTBP – GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies